Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

Bipolar Disorder in 10–17 Year Old Patients: Treatment Options and Cautions

Submit a Paper


Clinical Medicine Reviews in Therapeutics 2011:3

Review

Published on 28 Jun 2011

DOI: 10.4137/CMRT.S3084


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Therapeutics

Abstract

In recent years, bipolar disorder (BD) has been diagnosed with increasing frequency in the pediatric population. BD requires a multimodal treatment plan to address complex symptoms and the associated comorbidities. Pharmacological intervention assists the core symptoms of the illness and psychotherapeutic intervention may be beneficial as an adjunctive treatment. Controlled studies corroborate the comparable short-term efficacy of several second generation antipsychotics and mood stabilizers for treating mania, but major dissimilarities exist with respect to the kind and severity of side effects. The selected treatment option is determined by the tolerance and safety. In addition, data suggests that youth may be more vulnerable to the adverse effects of psychotropic medications than adults. More clinical trials, that focus on risk-benefit ratios of these medications and that clarify assessment and management of their comorbidities are needed to find safer and more effective treatment options for long-term treatment.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




What Your Colleagues Say About Libertas Academica
As a new contributor, my experience publishing our article in Genetics and Epigenetics was extremely positive.  The reviewing process was prompt and fair (four reviewers examined our review article!) and then, the editorial office was very helpful by regularly updating me on the progression of the publication process.  I strongly recommend the journal to my colleagues in the field and hope that the journal will grow up and gain the notoriety it deserves in our ...
Dr Sylviane Muller (Institut de Biologie Moléculaire et Cellulaire, CNRS, Strasbourg, France)
More Testimonials

Quick Links


New article and journal news notification services